Stock OMKARPH OMKAR PHARMACHEM LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Omkar Pharmachem Limited

Equities

OMKARPH

INE501C01015

Investment Holding Companies

Market Closed - Bombay S.E.
Other stock markets
 06:00:51 2024-05-16 EDT 		5-day change 1st Jan Change
21.95 INR -.--% Intraday chart for Omkar Pharmachem Limited -.--% +0.78%
05-30 Omkar Pharmachem Limited Announces Pankaj Mahadeo Singh Resigns as Company Secretary and Compliance Officer, Effective on June 15,2024 CI
02-14 Omkar Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 92.87 129.1 160.3 208.7 205.7 252.1
Enterprise Value (EV) 1 95.09 134.6 168.6 217.3 212.9 257
P/E ratio -36.3 x -30.5 x -61.2 x 94.3 x 113 x 127 x
Yield - - - - - -
Capitalization / Revenue - - 356,289,849 x 77,308,175 x 38,095,394 x 46,685,532 x
EV / Revenue - - 374,615,864 x 80,487,804 x 39,425,580 x 47,590,532 x
EV / EBITDA -40.2 x -35.5 x -82.5 x 997 x 79.2 x 82.7 x
EV / FCF -54.4 x -75.1 x -99 x -1,067 x 347 x 196 x
FCF Yield -1.84% -1.33% -1.01% -0.09% 0.29% 0.51%
Price to Book 1.02 x 1.48 x 1.9 x 2.41 x 2.33 x 2.79 x
Nbr of stocks (in thousands) 10,084 10,084 10,084 10,084 10,084 10,084
Reference price 2 9.210 12.80 15.90 20.70 20.40 25.00
Announcement Date 18-09-06 19-09-03 20-09-02 21-09-03 22-09-02 23-09-04
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales - - 0.45 2.7 5.4 5.4
EBITDA 1 -2.367 -3.797 -2.044 0.218 2.687 3.109
EBIT 1 -2.392 -3.832 -2.063 0.208 2.668 3.082
Operating Margin - - -458.54% 7.7% 49.41% 57.07%
Earnings before Tax (EBT) 1 -2.53 -4.206 -2.597 -0.359 2.105 2.645
Net income 1 -2.561 -4.202 -2.596 2.214 1.831 1.978
Net margin - - -576.89% 82% 33.91% 36.63%
EPS 2 -0.2539 -0.4200 -0.2600 0.2196 0.1800 0.1962
Free Cash Flow 1 -1.749 -1.793 -1.702 -0.2038 0.6136 1.314
FCF margin - - -378.26% -7.55% 11.36% 24.34%
FCF Conversion (EBITDA) - - - - 22.84% 42.28%
FCF Conversion (Net income) - - - - 33.51% 66.45%
Dividend per Share - - - - - -
Announcement Date 18-09-06 19-09-03 20-09-02 21-09-03 22-09-02 23-09-04
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 2.22 5.57 8.25 8.59 7.18 4.89
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.9364 x -1.467 x -4.035 x 39.38 x 2.673 x 1.572 x
Free Cash Flow 1 -1.75 -1.79 -1.7 -0.2 0.61 1.31
ROE (net income / shareholders' equity) -2.77% -4.72% -3.03% 2.59% 2.09% 2.21%
ROA (Net income/ Total Assets) -1.59% -2.56% -1.38% 0.14% 1.71% 1.97%
Assets 1 161.3 164.3 188.1 1,618 106.8 100.4
Book Value Per Share 2 9.050 8.630 8.370 8.590 8.770 8.970
Cash Flow per Share 2 0.0200 0.0200 0.0400 0.0400 0.2100 0.1300
Capex 1 0.06 - 0.02 - 0.07 -
Capex / Sales - - 3.33% - 1.26% -
Announcement Date 18-09-06 19-09-03 20-09-02 21-09-03 22-09-02 23-09-04
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
OMKAR PHARMACHEM LIMITED Stock Omkar Pharmachem Limited
+0.78% 2.65M
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+180.51% 8.67B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.29% 983M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 883M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+26.17% 825M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.92% 665M
E7 GROUP Stock E7 Group
+9.52% 664M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ADMIRAL ACQUISITION LIMITED Stock Admiral Acquisition Limited
+9.17% 530M
CAPITOL INVESTMENT CORP. VII Stock Capitol Investment Corp. VII
-.--% 500M
Shell Companies
  1. Stock Market
  2. Equities
  3. OMKARPH Stock
  4. Financials Omkar Pharmachem Limited